stockportfolio.pro
Stocks / DMRA vs TDOC
DMRA vs TDOC
Damora Therapeutics, Inc. and Teladoc Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Damora Therapeutics, Inc. (DMRA) | Teladoc Health, Inc. (TDOC) | |
|---|---|---|
| Market cap | $1.3B | $1.3B |
| Revenue (latest FY) | $0 | $2.53B |
| Net income (latest FY) | $-209.84M | $-200.32M |
| Revenue growth (5y CAGR) | — | 18.3% |
| Net margin | — | -7.9% |
| Return on equity | -87.3% | -14.5% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DMRA — free Open TDOC — freeFrequently asked questions
Which is bigger, DMRA or TDOC?
Damora Therapeutics, Inc. is larger by market capitalization — $1.3B versus $1.3B.
Which grows faster, DMRA or TDOC?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.